Y. Karube et al., Tumor scintigraphy by the method for subtracting the initial image with technetium-99m labeled antibody, ANN NUCL M, 13(6), 1999, pp. 407-413
The method for subtracting the initial image from the localization image wa
s evaluated for radioimmunoscintigraphy of tumors with technetium-99m (Tc-9
9m) labeled antibodies. Monoclonal antibodies were parental mouse and mouse
-human chimeric antibodies to carcinoembryonic antigen (CEA), designated F1
1-39 and ChF11-39, respectively, both of which have been found to discrimin
ate CEA in tumor tissues from the CEA-related antigens. After reduction of
the intrinsic disulfide bonds, these antibodies were labeled with Tc-99m. I
n vivo studies were performed on athymic nude mice bearing the human CEA-pr
oducing gastric carcinoma xenografts. Though biodistribution results showed
selective and progressive accumulation of Tc-99m labeled antibodies at the
tumor site, high radioactivity in blood was inappropriate for scintigraphi
c visualization of the tumors within a few hours. We examined the subtracti
on of the initial Tc-99m image from the Tc-99m localization image after a f
ew hours. Subtracted images of the same count reflected the in vivo behavio
r of the Tc-99m radioactivity. The subtracted scintigrams revealed excellen
t tumor images with no significant extrarenal background. Visualization of
the tumor site was dependent on antigen-specific binding and nonspecific ex
udation. These results demonstrate that a method of subtraction of the init
ial image may serve as a potentially useful diagnostic method for an abnorm
al site for agents with a low pharmacokinetic value.